Warning: This security is no longer trading.
Novartis completes tender offer for all outstanding shares of AveXis
AveXis, Inc. (AVXS): Price and Financial Metrics
AVXS Price/Volume Stats
| Current price | $217.94 | 52-week high | $217.94 |
| Prev. close | $217.83 | 52-week low | $65.54 |
| Day low | $217.94 | Volume | 222 |
| Day high | $217.94 | Avg. volume | 816,305 |
| 50-day MA | $173.48 | Dividend yield | N/A |
| 200-day MA | $120.18 | Market Cap | 8.02B |
AVXS Stock Price Chart Interactive Chart >
AveXis, Inc. (AVXS) Company Bio
AveXis, Inc., a clinical-stage gene therapy company, engages in developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. The company was founded in 2010 and is based in Bannockburn, Illinois.
AVXS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...